-
Combining Treatment With Hospice ServicesOrganizations are testing new models of end-of-life care that allow patients to start hospice without stopping treatment.
by Cheryl Platzman Weinstock
-
From the Editor-in-Chief
Improving Health After TreatmentThe U.S. health care system must adapt to the needs of cancer survivors.
by William G. Nelson, MD, PhD
-
Staying Close Through CancerCancer and its treatment can hinder sexual intimacy, but help is available. Talking about the problem is the first step.
by Cameron Walker
-
The Education of a Patient AdvocateBob Riter explains how his breast cancer diagnosis set him on a path to find his calling.
by Bob Riter
-
Sound Advice
Winter 2018/2019vol 08 | issue 04
Experts offer advice on accompanying a friend to a doctor's appointment, responding to a no evidence of disease diagnosis, and sharing the results of genetic testing. -
Forward Look
Alternatives to OpioidsThere are multiple options for managing cancer-related pain.
by Bradley Jones
-
Healthy Habits
Carb ConnectionCould consuming fewer simple carbohydrates lead to better cancer outcomes?
by Lindsey Konkel
-
Healthy Habits
Make Your MoveExercising during or after treatment can improve your health and outlook.
by Brenda Conaway
-
Forward Look
The Devastating Impact of Muscle WastingCachexia is a factor in cancer-related deaths.
by Delia O’Hara
-
Your Cancer Guide
Choose Your WorryDeciding when and what to worry about can help with gaining control over fear.
by Hester Hill Schnipper
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
